Register
Login:
Share:
Email Facebook Twitter




Immupharma Share Price (IMM)



Share Price Information for Immupharma (IMM)


Share Price: 28.50Bid: 27.00Ask: 30.00Change: 0.00 (0.00%)No Movement on Immupharma
Spread: 3.00Spread as %: 11.11%Open: 28.50High: 28.50Low: 28.50Yesterday’s Close: 28.50

Immupharma Plc Ord 10P

Immupharma is listed in the FTSE AIM All-Share
Immupharma is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
28.50

Share Price SpacerBid
27.00

Share Price SpacerAsk
30.00

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
17,118

Share Price SpacerOpen
28.50

Share Price SpacerHigh
28.50

Share Price SpacerLow
28.50

Share Price SpacerClose
28.50

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 121.78m £34.71m 10,000

52 Week High 50.00 52 Week High Date 5-JUN-2015
52 Week Low 19.75 52 Week Low Date 2-DEC-2015

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
5 0 17,118 -6.477 -4.40 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

27-May-16
10:59:01
29.37
6,776
Buy* 
27.00
30.00
1,990
Trade Type:
Ordinary

27-May-16
10:06:31
29.37
78
Buy* 
27.00
30.00
22.91
Trade Type:
Ordinary

27-May-16
09:10:13
29.37
1,702
Buy* 
27.00
30.00
499.88
Trade Type:
Ordinary




View more Immupharma trades >>

Directors Deals for Immupharma (IMM)
Trade DateActionNotifierPriceCurrencyAmountHolding
30-Apr-15Notification of Holding
Trade Notifier Information for Immupharma
Stephane Robert George Mery held the position of Non-Executive Director at Immupharma at the time of this trade.
 Stephane Robert George Mery
002259
24-Jan-13Sell
Trade Notifier Information for Immupharma
Ajay Agrawal held the position of Non-Executive Director at Immupharma at the time of this trade.
 Ajay Agrawal
57GBX62,1690
24-Jan-12Buy
Trade Notifier Information for Immupharma
Ajay Agrawal held the position of Non-Executive Director at Immupharma at the time of this trade.
 Ajay Agrawal
80GBX62,1690
View more Immupharma directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
Fri 07:22hunkymonkeyConsolidated higher sp29.50No Opinion
Struggling to break 30p, but lots of institutional investment here. More sites opened, it's still another year away before anything meaningful.

However I would expect the sp to be much higher at that time.

Since last December, this has been an absolute gift of an sp. We will get there.....
Fri 07:20McowboyLupuzor phase 3 trials29.50No Opinion
Clinical trials site updated to include Hungarian recruitment sites https://clinicaltrials.gov/ct2/show/study/NCT02504645?term=lupuzor&rank=1#contacts
Wed 11:04pomanderRE: Rns29.00No Opinion
I take this as a very positive sign.
Wed 09:09Jonah58RE: Rns29.00No Opinion
I agree. It's far to early to speculate about the trial, but if I was in charge of an asset management fund I would not increase my investment if I was aware of any major glitches. I think we can safeky assume that recruitment is on track.
Wed 07:27hunkymonkeyRE: Rns29.00No Opinion
Follow the money, it may just be coincidence however, a French investment company investing big in a pharma company that has most of its clinical trials in France.

Flow the money, imm has lots of institutional investors. This only bodes well. All is good here, albeit slow going. But this sp represents real value
Wed 07:22hunkymonkeyRns29.00No Opinion
ImmuPharma PLC (LSE:IMM) ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, announces that on 24 May 2016 it received notification by Alto Invest and its subsidiaries ("Alto") confirming its holding in ImmuPharma of 4,870,367 million Ordinary Shares in the capital of the Company, representing 3.99% of the Company's total voting rights, crossing above the 3% threshold.

Alto Invest is an independent asset management firm… Read More

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Immupharma (IMM) >>

Please login or register to post a message on Share Chat.






Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.